ストックスクリーナーアプリを入手
3.16
1.94%
0.06
プレマーケット:
3.16
前日終値:
$3.10
開ける：
$3.26
24時間の取引高:
87,717
Relative Volume:
0.69
時価総額：
$101.79M
収益：
-
当期純損益:
$-12.48M
株価収益率:
-8.1026
EPS:
-0.39
ネットキャッシュフロー:
$-7.93M
1週間 パフォーマンス:
-6.51%
1か月 パフォーマンス:
-1.86%
6か月 パフォーマンス:
+7.48%
1年 パフォーマンス:
+2.27%
1日の値動き範囲:
$3.12
$3.2786
1週間の範囲:
$3.10
$3.41
52週間の値動き範囲:
$2.07
$4.20
Anixa Biosciences Inc Stock (ANIX) Company Profile
名前
Anixa Biosciences Inc
セクター
電話
408-708-9808
住所
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
ANIX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
3.16 | 99.85M | 0 | -12.48M | -7.93M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-21 | 開始されました | Maxim Group | Buy |
| 2022-12-23 | 開始されました | Chardan Capital Markets | Buy |
| 2021-04-12 | 開始されました | H.C. Wainwright | Buy |
Anixa Biosciences Inc (ANIX) 最新ニュース
Anixa Biosciences stock rises after securing Canadian patent allowance - Investing.com Australia
Anixa Biosciences receives Canadian patent allowance for breast cancer vaccine - Investing.com Australia
First-Ever Breast Cancer Prevention Vaccine Technology Expands Global Patent Protection in Canada - Stock Titan
How Anixa Biosciences Inc. stock performs during market volatilityExit Ready Momentum Stock Watchlist Expanded - metal.it
Anixa Biosciences Inc. Earnings Report Breakdown: What Investors Should KnowEntry Plan for Oversold Reversal Stocks Released - metal.it
Should I hold or sell Anixa Biosciences Inc. stock in 2025Powerful market insights - jammulinksnews.com
What are the technical indicators suggesting about Anixa Biosciences Inc.Earnings Report Alerts For Every Investor - jammulinksnews.com
How does Anixa Biosciences Inc. compare to its industry peersMaximize your returns with expert insights - jammulinksnews.com
How many analysts rate Anixa Biosciences Inc. as a “Buy”Build wealth steadily with expert advice - jammulinksnews.com
What are analysts’ price targets for Anixa Biosciences Inc. in the next 12 monthsExplosive wealth accumulation - jammulinksnews.com
How strong is Anixa Biosciences Inc. company’s balance sheetBuild wealth with reliable stock picks - jammulinksnews.com
How Efficient Is Anixa Biosciences Inc. at Controlling Operating CostsFree Stock Movement Tracking - metal.it
What are the latest earnings results for Anixa Biosciences Inc.Achieve fast wealth growth with smart picks - jammulinksnews.com
Why is Anixa Biosciences Inc. stock attracting strong analyst attentionGrow your portfolio with growth-oriented stocks - jammulinksnews.com
What is the dividend policy of Anixa Biosciences Inc. stockBuild wealth faster with consistent investment plans - jammulinksnews.com
How volatile is Anixa Biosciences Inc. stock compared to the marketConsistent wealth multiplication - jammulinksnews.com
When is Anixa Biosciences Inc. stock expected to show significant growthFree Expert Stock Watchlist - jammulinksnews.com
Is Anixa Biosciences Inc. stock overvalued or undervaluedTremendous return rates - jammulinksnews.com
Why Anixa Biosciences Inc. stock attracts strong analyst attentionLong Term Safe Yield Focus - metal.it
What analysts say about Anixa Biosciences Inc. stockExplosive capital gains - PrintWeekIndia
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is Anixa Biosciences Inc. a good long term investmentSuperior risk-adjusted returns - PrintWeekIndia
What institutions are buying Anixa Biosciences Inc. stock nowBreakthrough profits - jammulinksnews.com
Anixa Biosciences receives new patent for breast cancer vaccine technology - Investing.com Australia
Revolutionary Breast Cancer Prevention Vaccine Secures Patent Protection Until 2040s$Billion Market Potential - Stock Titan
What drives Anixa Biosciences Inc. stock priceBreakthrough capital growth - Autocar Professional
Anixa Biosciences director Baskies buys $16,950 in stock By Investing.com - Investing.com South Africa
Anixa Biosciences director Baskies buys $16,950 in stock - Investing.com
Anixa Biosciences Inc (ANIX) 財務データ
収益
当期純利益
現金流量
EPS
Anixa Biosciences Inc (ANIX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Titterton Lewis H jr | Director |
Jul 11 '25 |
Buy |
3.14 |
10,000 |
31,400 |
943,334 |
| KUMAR AMIT | Chief Executive Officer |
Jul 11 '25 |
Buy |
3.15 |
5,000 |
15,750 |
574,925 |
| KUMAR AMIT | Chief Executive Officer |
Jun 04 '25 |
Buy |
2.85 |
10,000 |
28,500 |
569,925 |
| Baskies Arnold M | Director |
Jan 28 '25 |
Buy |
2.82 |
5,000 |
14,100 |
120,000 |
| Titterton Lewis H jr | Director |
Jan 23 '25 |
Buy |
2.91 |
2,000 |
5,820 |
932,334 |
| Titterton Lewis H jr | Director |
Jan 24 '25 |
Buy |
3.00 |
1,000 |
3,000 |
933,334 |
| Titterton Lewis H jr | Director |
Jan 22 '25 |
Buy |
3.01 |
2,000 |
6,020 |
930,334 |
| Titterton Lewis H jr | Director |
Jan 21 '25 |
Buy |
2.59 |
6,000 |
15,540 |
928,334 |
| Titterton Lewis H jr | Director |
Jan 17 '25 |
Buy |
2.57 |
10,000 |
25,700 |
922,334 |
| KUMAR AMIT | Chief Executive Officer |
Jan 15 '25 |
Buy |
2.23 |
43,000 |
95,890 |
559,925 |
0.23%
0.40%
大文字化:
|
ボリューム (24 時間):